ALTAVIVA

Report

Report Number: 3004209178-2025-20188
Event Type: Injury
Date Received: November 26, 2025
Date of Event: October 29, 2025
Report Date: March 27, 2026
Manufacturer: MEDTRONIC PUERTO RICO OPERATIONS CO.
Product Code: QPT
UDI-DI: 00763000936433
PMA / PMN Number: P240011
Adverse Event: Yes
Report Source: Manufacturer report
Reporter Location: MO, US
Reporter Occupation: 003

Narratives

Additional Manufacturer Narrative · 0

MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.

Additional Manufacturer Narrative · 0

MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.

Additional Manufacturer Narrative · 0

MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.

Description of Event or Problem · 0

INFORMATION WAS RECEIVED FROM A CONSUMER VIA A MANUFACTURER¿S REPRESENTATIVE REGARDING A PATIENT WHO WAS IMPLANTED WITH AN IMPLANTABLE NEUROSTIMULATOR (INS) FOR URINARY/BOWEL DYSFUNCTION. IT WAS REPORTED THAT THE PATIENT COMPLAINED OF REDNESS AND WARMTH AT THEIR INCISION SITE. THE HCP SAW THEM LATER THAT DAY AND IT WAS DETERMINED THAT THE DEVICE NEEDED TO BE EXPLANTED. IT WAS NOTED THAT THE PATIENT HAS SEVERAL ALLERGIES AND THE HCP THOUGHT THIS COULD PERHAPS BE AN ALLERGIC REACTION TO THE SILICONE COATING OF THE DEVICE. IT WAS ALSO NOTED THAT IT WAS A SUSPECTED INFECTION; THEY EXPERIENCED REDNESS, WARMTH/HOT, AND DISCHARGE/WOUND WEEPING. ANTIBIOTICS WERE REQUIRED AND EXPLANT WAS PLANNED FOR THE AFTERNOON OF (B)(6) 2025. ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT AND THE HEALTHCARE PROFESSIONAL VIA A MANUFACTURER REPRESENTATIVE. THE HCP VIA THE REP STATED THAT THEY WERE SURE THIS WAS A CASE OF ALLERGIC REACTION AND NOT INFECTION. THEY STATED THAT THE POCKET WAS DRY, AND THE WOUND WAS NOT HOT; IT WAS RED AND LOOKED IRRITATED, BUT THERE WAS NO HEAT. THE REP STATED THAT THEY WERE SURE THE HCP SENT THE PATIENT HOME WITH ANTIBIOTICS AFTER OPENING THE INCISION BACK UP. WHEN ASKED IF THIS WAS PROPHYLACTIC ANTIBIOTIC USE, HE STATED, ¿YEA, I CAN¿T IMAGINE [THE HCP] WOULDN¿T PUT THEM ON ANTIBIOTICS AFTER OPENING IT UP.¿ THE REP ALSO NOTED THAT ALTHOUGH THEY¿RE SAYING IT¿S A SILICONE ALLERGY, THE REP BELIEVES IT COULD BE TITANIUM, OR METAL. THE PATIENT REPORTED THAT ON (B)(6) IT WAS DISCOVERED THAT THEY WERE HAVING AN ALLERGIC REACTION TO THE SILICONE THE DEVICE WAS "COVERED IN". AT FIRST, THEY THOUGHT IT WAS AN INFECTION BUT THEN DETERMINED IT WAS A SILICONE ALLERGY. PATIENT HAD THE DEVICE REMOVED EARLIER THIS WEEK, ON (B)(6). PATIENT STATED THEY ARE STILL HAVING ISSUES WITH OOZING AND ITS PRETTY NASTY AND ARE ON ANTIBIOTICS. THEY ARE PLANNING TO HAVE THE STITCHES REMOVED ON (B)(6). PATIENT STATED THEY DID NOT KNOW THEY HAD A SILICONE ALLERGY PRIOR TO IMPLANT. IT WAS NOTED THAT THE PATIENT HAD A LONG LIST OF ALLERGIES. ADDITIONAL INFORMATION WAS RECEIVED FROM A HEALTHCARE PROFESSIONAL (HCP) VIA A MANUFACTURER REPRESENTATIVE. THE REP SPOKE WITH THE HCP OVER THE WEEKEND OF (B)(6) AND THEY SAID THE CULTURE CAME BACK NEGATIVE AND THEY HAD NOT STARTED THE PATIENT ON ANY ANTIBIOTICS. PATIENT IS DOING WELL AND CLEARLY NOT AN INFECTION BUT AN ALLERGIC REACTION.¿ WHEN ASKED HOW THE PATIENT WAS DOING POST-OP, THE REP REPORTED THAT THE HCP ¿SAID [THEY WERE] DOING WELL AND HEALING WITHOUT ISSUE.¿ THE REP ALSO PROVIDED A PICTURE OF THE ANKLE FROM (B)(6) 2025.

Devices

Seq	Brand	Generic	Product Code	Manufacturer	Model	Lot	UDI-DI
2568976	ALTAVIVA	STIMULATOR, TIBIAL, ELECTRICAL, IMPLANTABLE, FOR URINARY INCONTINENCE	QPT	MEDTRONIC PUERTO RICO OPERATIONS CO.	P7850N		00763000936433

Patients

Seq	Age	Sex	Outcome	Treatment
1	78 YR	Female	Required Intervention